Singapore Clinical Trial: A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy (ACT-EARLY OLE)

Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed... Read More

Clinical Trial: Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07645820) titled 'Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares' on Jun... Read More

Singapore Clinical Trial: Healthy longevity with rapamycin (LONGER)

Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'Healthy longevity with rapamycin (LONGER)'. The following are the other relevant details related t... Read More

Singapore Clinical Trial: FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma

Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma... Read More

Singapore Clinical Trial: Efficacy and safety of LUCONAC ® External Solution for the treatment of Onychomycosis in anopen label head-to-head comparison with Amorolfine Nail Lacquer.

Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'Efficacy and safety of LUCONAC ® External Solution for the treatment of Onychomycosis in anopen la... Read More

Singapore Clinical Trial: A multicenter, randomized, participant- and investigator - blinded, placebo-controlled, phase 2a study to assess the efficacy, safety and tolerability of GIA632 in adult participants with moderate to severe atopic dermatitis

Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, participant- and investigator - blinded, placebo-controlled, phase 2a s... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More

Clinical Trial: IPACK vs Adductor Magnus Plane Block Added to Adductor Canal Block for Total Knee Arthroplasty

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07643883) titled 'IPACK vs Adductor Magnus Plane Block Added to Adductor Canal Block for Total Knee Arthropla... Read More

Singapore Clinical Trial: Using AS01 adjuvant to improve immune response in older adults through trained immunity

Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'Using AS01 adjuvant to improve immune response in older adults through trained immunity'. The foll... Read More

Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, June 13 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More

• ««
• «
• 38459
• 38460
• 38461
• 38462
• 38463
• 38464
• 38465
• 38466
• 38467
• 38468
• »
• »»